SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia.
Quote | Sohm Inc (OTCMKTS:SHMN)
Last: | $0.001 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0009 |
Close: | $0.001 |
High: | $0.001 |
Low: | $0.00085 |
Volume: | 5,121,104 |
Last Trade Date Time: | 07/23/2024 03:00:00 am |
News | Sohm Inc (OTCMKTS:SHMN)
2024-06-10 13:45:34 ET CAR T-cell therapy has seen significant growth and much promise, as it provides targeted and personalized treatment for patients with certain types of cancer, particularly those that have not responded to traditional forms of treatment such as chemotherapy or radiatio...
CHINO HILLS, CA / ACCESSWIRE / June 10, 2024 / SOHM, Inc. (OTC PINK:SHMN) (the "Company"), a pharmaceutical and upstart biotechnology company that manufactures and markets generic drugs covering numerous treatment categories, announced that preliminary data from a 3 rd party user resulted in AB...
Message Board Posts | Sohm Inc (OTCMKTS:SHMN)
Subject | By | Source | When |
---|---|---|---|
I really hope sohm can show this new | MPstock | investorshub | 05/01/2023 11:44:08 AM |
$SHMN: MDP: Barron has proven himself to be | ChartTRACKER | investorshub | 04/30/2023 3:26:17 PM |
Attorney Letter Filed | Myth | investorshub | 04/28/2023 12:25:28 PM |
Unfortunately you're right | MPstock | investorshub | 04/27/2023 7:14:33 PM |
If it's good, bad or fake news we | jrsh | investorshub | 04/27/2023 5:45:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Sohm Inc Company Name:
SHMN Stock Symbol:
OTCMKTS Market:
2024-06-10 13:45:34 ET CAR T-cell therapy has seen significant growth and much promise, as it provides targeted and personalized treatment for patients with certain types of cancer, particularly those that have not responded to traditional forms of treatment such as chemotherapy or radiatio...
CHINO HILLS, CA / ACCESSWIRE / June 10, 2024 / SOHM, Inc. (OTC PINK:SHMN) (the "Company"), a pharmaceutical and upstart biotechnology company that manufactures and markets generic drugs covering numerous treatment categories, announced that preliminary data from a 3 rd party user resulted in AB...
SOHM (OTC: SHMN) , a leading generic pharmaceutical and upstart biotechnology company, today announced its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. The technology holds the potential to revolutionize gen...